Br.small Co.2 Regulatory News (BSC)

8 Feb 2006 16:14

Cozart PLC08 February 2006 Cozart plc Holding(s) in Company Abingdon, Oxfordshire UK, 8 February 2006: Cozart plc ('Cozart' or the'Company') have been advised that the shareholding of the British SmallerTechnology Companies VCT plc ('BSTC') in the Company has been transferred to theBritish Smaller Technology Companies VCT 2 plc. The BSTC held 3,885,775 ordinary shares in Cozart at the date of the transfer (8December 2005) and all these ordinary shares have been transferred. The register of members will be updated to reflect the following revisedholdings: Shareholder Number of ordinary Number of ordinary Number of ordinary Percentage of issued shares held prior to shares transferred shares held post ordinary share reorganisation reorganisation capital held post reorganisationBritish Smaller 3,885,775 (3,885,775) NIL 0.00%Technology Companies VCT plc British Smaller 1,177,251 3,885,775 5,063,026 5.09%Technology Companies VCT 2 plc TOTAL 5,063,026 NIL 5,063,026 5.09% EnquiriesCozart plcKatharine Wright, Company SecretaryTel: +44 (0)1235 861 483 Financial DynamicsBen Atwell/Davina LangdaleTel: +44 (207) 831 3113 About Cozart Cozart is a medical diagnostics company which develops, manufactures and sellsimmunodiagnostic tests, predominantly those used for the detection of drugs ofabuse. Cozart's products include laboratory based testing kits for the detectionof drugs in a variety of biological samples and the Cozart(R) RapiScan system, aportable device used for the on-site testing of drugs of abuse in saliva (oralfluid) samples. In July 2004 Cozart floated on London's AIM (trading symbol:CZT) following a successful fundraising with financial institutions. Cozart hassubsidiaries in Spain (Spinreact SA), Italy (Cozart Italia s.r.l.) and Sweden(Medib Skandinavien AB). This information is provided by RNS The company news service from the London Stock Exchange